Prophylaxis against renal ischemia-reperfusion injury in canine model: Stem cell approach
暂无分享,去创建一个
Y. Osman | N. Barakat | A. Shaaban | M. Gabr | S. Hamed | A. Mosbah | M. Gaballah | S. Khater
[1] Yiqiang Cao,et al. Klotho gene‐modified BMSCs showed elevated antifibrotic effects by inhibiting the Wnt/β‐catenin pathway in kidneys after acute injury , 2018, Cell biology international.
[2] D. Campagnol,et al. Adipose tissue derived mesenchymal stem cell transplantation in the treatment of ischemia/reperfusion induced acute kidney injury in rats. Application route and therapeutic window1. , 2018, Acta cirurgica brasileira.
[3] P. Gianello,et al. Improvement of mesh recolonization in abdominal wall reconstruction with adipose vs. bone marrow mesenchymal stem cells in a rodent model. , 2017, Journal of pediatric surgery.
[4] N. Barakat,et al. PROPHYLAXIS AGAINST RENAL ISCHEMIA REPERFUSION INJURY IN CANINE MODEL: STEM CELL APPROACH.: MP41‐02 , 2017 .
[5] Z. Han,et al. Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta , 2016, Stem Cell Research & Therapy.
[6] Amin Tamadon,et al. Isolation, Characterization and Growth Kinetic Comparison of Bone Marrow and Adipose Tissue Mesenchymal Stem Cells of Guinea Pig , 2016, International journal of stem cells.
[7] D. Woo,et al. Comparison of adult stem cells derived from multiple stem cell niches , 2016, Biotechnology Letters.
[8] M. Conzemius,et al. Comparison of Mesenchymal Stem Cell Surface Markers from Bone Marrow Aspirates and Adipose Stromal Vascular Fraction Sites , 2016, Front. Vet. Sci..
[9] J. Kastrup,et al. Comparison of clinical grade human platelet lysates for cultivation of mesenchymal stromal cells from bone marrow and adipose tissue , 2016, Scandinavian journal of clinical and laboratory investigation.
[10] F. Jouret,et al. Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[11] Allison Hubel,et al. Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices , 2014, Transfusion.
[12] Y. Osman,et al. Is solitary kidney really more resistant to ischemia? An experimental canine study. , 2013, The Journal of urology.
[13] T. Du,et al. Human Wharton’s jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells , 2013, Stem Cell Research & Therapy.
[14] R. Müller,et al. Survival and distribution of injected haematopoietic stem cells in acute kidney injury. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[15] Jian-ming Tan,et al. Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats. , 2013, Transplantation proceedings.
[16] N. Câmara,et al. Adipose Tissue-Derived Stem Cell Treatment Prevents Renal Disease Progression , 2012, Cell transplantation.
[17] L. Lerman,et al. Adipose Tissue‐Derived Mesenchymal Stem Cells Improve Revascularization Outcomes to Restore Renal Function in Swine Atherosclerotic Renal Artery Stenosis , 2012, Stem cells.
[18] S. Böhm,et al. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC , 2011, Cell Communication and Signaling.
[19] S. Kang,et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. , 2011, Stem cells and development.
[20] L. Lerman,et al. Endothelial Progenitor Cells Homing and Renal Repair in Experimental Renovascular Disease , 2010, Stem cells.
[21] A. Gruber,et al. Limited immune-modulating activity of porcine mesenchymal stromal cells abolishes their protective efficacy in acute kidney injury. , 2010, Stem cells and development.
[22] A. Faussat,et al. Evaluation of the effect of autologous mesenchymal stem cell injection in a large‐animal model of bilateral kidney ischaemia reperfusion injury , 2009, Cell proliferation.
[23] Leelee Ong,et al. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. , 2009, Microvascular research.
[24] W. Frishman,et al. Stem cell therapy for the kidney? , 2009, American journal of therapeutics.
[25] M. Sogayar,et al. Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. , 2009, Transplantation proceedings.
[26] E. Goloni-Bertollo,et al. Effect of whole bone marrow cell infusion in the progression of experimental chronic renal failure. , 2008, Transplantation proceedings.
[27] A. Caplan,et al. The Dynamic in vivo Distribution of Bone Marrow-Derived Mesenchymal Stem Cells after Infusion , 2001, Cells Tissues Organs.
[28] A. Novick. Renal hypothermia: in vivo and ex vivo. , 1983, The Urologic clinics of North America.
[29] R. Bulger,et al. Survey of the morphology of the dog kidney , 1979, The Anatomical record.
[30] Punit Kumar,et al. Anatomical and Physiological Similarities of Kidney in Different Experimental Animals Used for Basic Studies , 2018 .
[31] M. Boim,et al. Mesenchymal stem cells and chronic renal artery stenosis. , 2016, American journal of physiology. Renal physiology.